All content on this site is intended for healthcare professionals only. By acknowledging this message and accessing the information on this website you are confirming that you are a Healthcare Professional. If you are a patient or carer, please visit Know AML.

The AML Hub uses cookies on this website. They help us give you the best online experience. By continuing to use our website without changing your cookie settings, you agree to our use of cookies in accordance with our updated Cookie Policy

How does COVID-19 affect outcomes in AML?

During the EHA2021 Virtual Congress, the AML Hub spoke with Olga Gavrilina, National Research Center for Hematology, Moscow, RU. We asked, How does COVID-19 affect outcomes in AML?

How does COVID-19 affect outcomes in AML?

In this video, Gavrilina evaluates treatment outcomes, risk factors, prognosis, and mortality rates related to patients with AML and SARS-CoV-2 infection in a real-world setting.

 

Share: